Oncolytic virus and immunogenic cell death in cancer therapy
Open Access
- 27 November 2025
- journal article
- review article
- Published by Elsevier in Tumour Virus Research
- Vol. 20, 200333
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32272978)
This publication has 343 references indexed in Scilit:
- Humanized mouse models: A valuable platform for preclinical evaluation of human cancerBiotechnology and Bioengineering, 2023
- Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced MelanomaJAMA Oncology, 2023
- Single‐cell transcriptome analysis reveals cellular and molecular alterations in small cell lung cancer tumors following chemotherapyInternational Journal of Cancer, 2023
- The role of toll‐like receptor 4 (TLR4) in cancer progression: A possible therapeutic target?Journal of Cellular Physiology, 2020
- Targeting immunogenic cell death in cancerMolecular Oncology, 2020
- A Dual Role of Type I Interferons in Antitumor ImmunityAdvanced Biosystems, 2020
- Oncolytic Viruses in Cancer TreatmentJAMA Oncology, 2017
- Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcomaInternational Journal of Cancer, 2016
- The destructive effect of the virus of russian far east encephalitis on the transplantable mouse sarcoma 180Cancer, 1949
- Effect of inoculation of the viruses of influenza a and herpes simplex on the growth of transplantable tumors in miceCancer, 1949